Literature DB >> 25763511

Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease.

Loren D M Pena1, Alan D Proia, Priya S Kishnani.   

Abstract

Pompe disease (OMIM 232300), a glycogen storage disorder caused by deficiency in the lysosomal enzyme acid alpha-glucosidase (EC 3.2.1.20), results in weakness and cardiomyopathy in infants affected with the classic form. Although the primary disease manifestations are due to glycogen accumulation in skeletal and cardiac muscle, glycogen also accumulates in a variety of additional tissues. To improve our understanding of disease pathogenesis in long-term survivors, we reviewed postmortem results for three infants with the classic form of Pompe disease. We have observed a number of new complications in long-term survivors of infantile-onset Pompe disease, and we focused this postmortem study on pathological correlates. Findings in survivors include cardiac arrhythmias, which may be related to glycogen accumulation in cardiac conduction tissue; urinary incontinence, likely due to glycogen accumulation in smooth muscle; and refractory errors, possibly related to accumulation in ocular structures. These observations provide potential pathophysiologic correlates for complications in long-term survivors of infantile Pompe disease.

Entities:  

Year:  2015        PMID: 25763511      PMCID: PMC4484900          DOI: 10.1007/8904_2015_426

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  36 in total

1.  Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition.

Authors:  Gauthier Remiche; Anne-Geneviève Herbaut; Dario Ronchi; Costanza Lamperti; Francesca Magri; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  Eur Neurol       Date:  2012-06-29       Impact factor: 1.710

2.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

3.  Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts.

Authors:  Véronique Quenardelle; Marc Bataillard; Dorothée Bazin; Béatrice Lannes; Valérie Wolff; Andoni Echaniz-Laguna
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

4.  Glycogenosis type II (Pompe). The fourth autopsy case in Japan.

Authors:  I Sakurai; A Tosaka; Y Mori; S Imura; K Aoki
Journal:  Acta Pathol Jpn       Date:  1974-11

5.  Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2.

Authors:  C Martini; G Ciana; A Benettoni; F Katouzian; G M Severini; R Bussani; B Bembi
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

6.  The conduction system in Pompe's disease.

Authors:  S Bharati; M Serratto; I DuBrow; M H Paul; S Swiryn; R A Miller; K Rosen; M Lev
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

7.  Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Shinn-Forng Peng; Wuh-Liang Hwu
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

8.  Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up.

Authors:  Gail A Spiridigliozzi; James H Heller; Priya S Kishnani
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

9.  Basilar artery aneurysm: a new finding in classic infantile Pompe disease.

Authors:  Trusha T Patel; Suhrad G Banugaria; Donald P Frush; David S Enterline; Pranoot Tanpaiboon; Priya S Kishnani
Journal:  Muscle Nerve       Date:  2013-02-10       Impact factor: 3.217

10.  The emerging phenotype of long-term survivors with infantile Pompe disease.

Authors:  Sean N Prater; Suhrad G Banugaria; Stephanie M DeArmey; Eleanor G Botha; Erin M Stege; Laura E Case; Harrison N Jones; Chanika Phornphutkul; Raymond Y Wang; Sarah P Young; Priya S Kishnani
Journal:  Genet Med       Date:  2012-04-26       Impact factor: 8.822

View more
  14 in total

Review 1.  Liver depot gene therapy for Pompe disease.

Authors:  Priya S Kishnani; Dwight D Koeberl
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

3.  Airway smooth muscle dysfunction in Pompe (Gaa-/- ) mice.

Authors:  Allison M Keeler; Donghai Liu; Marina Zieger; Lang Xiong; Jeffrey Salemi; Karl Bellvé; Barry J Byrne; David D Fuller; Ronghua ZhuGe; Mai K ElMallah
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-23       Impact factor: 5.464

Review 4.  Long-term outcome and unmet needs in infantile-onset Pompe disease.

Authors:  Andreas Hahn; Anne Schänzer
Journal:  Ann Transl Med       Date:  2019-07

5.  rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.

Authors:  Hanmeng Zhang; Murtaza S Nagree; Haoyuan Liu; Xiaoqing Pan; Jeffrey A Medin; Daniel M Lipinski
Journal:  Gene Ther       Date:  2022-07-28       Impact factor: 4.184

6.  Novel approaches to quantify CNS involvement in children with Pompe disease.

Authors:  Aditi Korlimarla; Gail A Spiridigliozzi; Kelly Crisp; Mrudu Herbert; Steven Chen; Michael Malinzak; Mihaela Stefanescu; Stephanie L Austin; Heidi Cope; Kanecia Zimmerman; Harrison Jones; James M Provenzale; Priya S Kishnani
Journal:  Neurology       Date:  2020-06-09       Impact factor: 9.910

7.  Multicentric Retrospective Evaluation of Five Classic Infantile Pompe Disease Subjects Under Enzyme Replacement Therapy With Early Infratentorial Involvement.

Authors:  Matteo Paoletti; Anna Pichiecchio; Giovanna Stefania Colafati; Giorgio Conte; Federica Deodato; Serena Gasperini; Francesca Menni; Francesca Furlan; Laura Rubert; Fabio Maria Triulzi; Claudia Cinnante
Journal:  Front Neurol       Date:  2020-11-25       Impact factor: 4.003

8.  Glycogen accumulation in smooth muscle of a Pompe disease mouse model.

Authors:  Angela L McCall; Justin S Dhindsa; Aidan M Bailey; Logan A Pucci; Laura M Strickland; Mai K ElMallah
Journal:  J Smooth Muscle Res       Date:  2021

Review 9.  The Respiratory Phenotype of Pompe Disease Mouse Models.

Authors:  Anna F Fusco; Angela L McCall; Justin S Dhindsa; Lucy Zheng; Aidan Bailey; Amanda F Kahn; Mai K ElMallah
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

Review 10.  Pompe Disease: New Developments in an Old Lysosomal Storage Disorder.

Authors:  Naresh K Meena; Nina Raben
Journal:  Biomolecules       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.